Bromodeoxyuridine

A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.

Also Known As:

BrdU; Broxuridine; 5 Bromodeoxyuridine; 5-Bromo-2'-deoxyuridine; 5-Bromodeoxyuridine; NSC-38297; 5 Bromo 2' deoxyuridine; Deoxyriboside, Bromouracil; BUdR; Bromouracil Deoxyriboside; Uridine, 5-bromo-2'-deoxy-

Pharmalogical Action Categories:

Antimetabolites
Antimetabolites, Antineoplastic
Antiviral Agents
Radiation-Sensitizing Agents

-

Heterocyclic Compounds: 25

-

1-Ring Heterocyclic Compounds

-

Pyrimidines: 281

-

Pyrimidine Nucleosides: 38

-

Uridine: 780

-

Deoxyuridine: 241

*

Bromodeoxyuridine: 2342

-

Nucleic Acids, Nucleotides, and Nucleosides: 1

-

Nucleosides: 612

-

Pyrimidine Nucleosides: 38

-

Uridine: 780

-

Deoxyuridine: 241

*

Bromodeoxyuridine: 2342

-

Deoxyribonucleosides: 28

-

Deoxyuridine: 241

*

Bromodeoxyuridine: 2342

C Peillon Selected Research

Articles by Research Topic

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure